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Abstract: Bovine ephemeral fever (BEF) is a common febrile disease in cattle in tropical countries causing loss of milk
production and reproductive performance. Recently, severe outbreaks have occurred in many countries in East Asia, the
Middle East, and Southeast Asia, especially in the rainy season, while limited vaccines and diagnostic tools are available.
Thus, the aim of this study was to produce a secreted, soluble form of BEFV G glycoprotein in insect cells for further
applications. BEFV G gene expressing transmembrane-deleted G glycoprotein (G∆TM) was constructed and cloned into
the baculovirus vector. The recombinant G∆TM protein was expressed in High5 insect cells and then purified by affinity
chromatography. The purified G∆TM reacted specifically with a convalescent bovine serum. Four 8-week-old Wistar rats
were injected subcutaneously with the purified G∆TM protein. Postimmunized rat serum samples also strongly reacted
with the G protein by western blot and immunoperoxidase mono player assay (IPMA). These results indicated the potential
use of the transmembrane-deleted G protein to develop protein based-diagnostic tools for BEFV control programs.
Key words: Bovine ephemeral fever virus, truncated G protein, protein expression, baculovirus expression system,
diagnostic tool
1. Introduction
Bovine ephemeral fever virus (BEFV) is classified in the
genus Ephemerovirus, family Rhabdoviridae. It causes an
acute febrile disease in cattle and water buffalo transmitted
by Culicoides biting mosquitoes (1,2). The BEFV genome is
14.9 kb in length and contains a nonsegmented, negativesense, single-stranded RNA encoding five structural
proteins: nucleoprotein (N), phosphoprotein (P), matrix
protein (M), glycoprotein (G), and a large multifunctional
enzyme (L) (3,4). The G protein is a class I transmembrane
glycoprotein located on the virion envelope. It induces
protective immunity including virus-specific neutralizing
antibodies (5,6). BEFV G protein comprises an N-terminal
signal peptide (amino acid 1–12), a C-terminal
transmembrane domain, and a cytoplasmic tail (amino
acids 522–623). The native BEFV G protein present on the
virion is 81 kDa but the recombinant G protein expressed
in insect cells appears to be either 76 or 71 kDa (7).
Four antigenic sites on the G protein (G1–G4) were well
* Correspondence: fvetptn@ku.ac.th
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characterized by sequence analysis and protein mapping
using specific monoclonal antibodies (7–9). G1–G3 sites
are located at amino acid 18–521 on the ectodomain
between the signal peptide and transmembrane domain of
the G protein (7,9).
Bovine ephemeral fever (BEF) is endemic in tropical
and subtropical regions of Africa, Asia, and Australia.
Outbreaks occur mostly during the rainy season (10–
12). The clinical signs of BEF in cattle include fever,
inappetence, lameness, recumbency, and decreased milk
production (13). Effective disease prevention and control
require both vaccines and diagnostic tools. Various
diagnostic procedures have been developed for BEFV
such as the loop-mediated isothermal amplification assay
(LAMP) (14) and enzyme-linked immunosorbent assay
(ELISA) (15–18). ELISA, which is based mainly on the
reactivity between protein antigens and theirs cognate
antibodies, has been widely established according to high
sensitivity and simplicity. G1-epitope, a highly conserved
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and antigenic region located on amino acids 487–503
of BEFV G protein, was previously expressed in E. coli
(15,19) and yeast (17,20). This epitope has been shown to
be a candidate antigen for ELISA development.
Genetic analysis revealed three clusters of BEFVs (21).
Cluster I contains BEFVs from East Asia. Most BEFVs
in clusters II and III were from Israel and Australia,
respectively. The recent whole genome analysis of the
highly pathogenic bovine ephemeral fever virus isolated
in Turkey classified it in cluster II (22). Thai BEFV is in
cluster I (our unpublished data). Antigenic properties of
different BEFV strains were dissimilar as some amino
acids on neutralizing epitopes were different (11,21). Thus,
a protein-based diagnostic assay developed from the local
strain would be a more effective tool for disease control
(23).
In the present study, we examined the expression and
purification of the baculovirus-expressed transmembranedeleted G protein (G∆TM) of BEFV cluster I in insect
cells. The purified G∆TM reacted well with a convalescent
bovine serum. Immunogenicity of the protein was
examined by rat immunization. The results show that the
G∆TM protein has a potential use for BEFV diagnosis.
2. Materials and methods
2.1. Cells
Spodoptera frugiperda (Sf9) cells were maintained in
Grace’s Insect Medium/Hink’s TNM-FH (Caissonlabs)
supplemented with 10% fetal calf serum, 2% pluronic
acid (Sigma), 12 mM L-glutamine, and 1X antibiotics/
antimycotics (Invitrogen). Trichoplusia ni (High5) cells
were maintained in a serum-free medium, Express Five
SFM (Invitrogen), at 26 °C.
2.2. Cloning of the full-length G gene
BEFV RNA was isolated from a serum sample obtained
from an infected calf by using a viral nucleic acid extraction
kit II (Gene-aid) following the manufacturer’s instruction.
The isolated total RNA in RNase-free water was measured
by Nanodrop (Thermo Scientific). One microgram of

the total RNA was reverse transcribed using a randomhexamer primer and Superscript III reverse transcriptase
(Invitrogen). cDNA was used as the template to amplify
a full-length G gene with specific primers, BEF_G1F and
BEF_G1R (Table). The PCR reaction contained 1X HF
buffer (Thermo Scientific), 0.5 mM dNTP, and 0.2 µM of
each primer and Phusion tag DNA polymerase (Thermo
Scientific). The PCR cycle was 98 °C for 2 min, followed
by 35 cycles of 98 °C for 10 s, 60 °C for 15 s, and 72 °C
for 1 min plus an extension at 72 °C for 10 min. The PCR
products were separated by electrophoresis in 1% agarose
gel, stained with ethidium bromide and visualized under
UV light. The full-length G gene was purified and cloned
into pGEM-T easy vector (Promega), resulting in pBEF_G.
The plasmid was submitted for sequencing (Macrogen).
the G gene was then amplified from pBEF_G and cloned
into pFastBac HT/b (Invitrogen).
2.3. Construction of the transmembrane-deleted G gene
(G∆TM)
pFastBac_HTB vector (Invitrogen) was modified by
insertion of secretory peptide of Drosophila, BiP, so called
pFB_Bip, using a QuikChange Site-Directed Mutagenesis
Kit (NEB) following the manufacturer’s instruction.
Bip31_HisF and Ph_Bip1_R primers used for pFB_Bip
construction (Table) were designed according to the BiP
sequence in the pMT/BiP/V5-His A, B, and C manual
(Invitrogen). His8- tag was also inserted into pFB_Bip by
using QuikChange Site-Directed Mutagenesis Kit (NEB)
with His_AgeApaI_F and EK_His_ R primers as shown in
the Table, resulting in the so-called plasmid pFBip_His8.
N-terminal signal peptide (amino acids 1–12),
C-terminal transmembrane domain, and cytoplasmic tail
(amino acids 522–623) were removed from the plasmid
containing the full length G gene, pBEF_G, to generate
the G∆TM gene fragment (8) by PCR with primers AgeI_
G13F and XhoI_G522R as shown in the Table. The G∆TM
fragment was cloned into pFBip_His8 between AgeI and
XhoI restriction enzyme sites. The recombinant plasmid
was named pFBip_G∆TM and it contains 5’-Bip (18

Table. Primers used in this study.
Primers

Sequences

BEF_G1F
BEF_G1R
Bip31_HisF
Ph_Bip1_R
His_AgeApaI_F
EK_His_ R
AgeI_G13F XhoI_G522R

ATGTTCAAGGTCCTAATAATTAC TTAATGATCAAAGAATCTGTCATC
GCCTTTGTTGGCCTCTCGCTCGGGAGATCTACCGGTCATCACCATCACCATCACGATTACGATATCCCAAC
CACGACGGCCAGTAATATGCATAACTTCATCCCGGGGGTTTCGGACCGAGATCCGCGCCCGATGGTGGGAC
CATCACCATCACTGAGATATCGGGCCCAAGCTTGTCGAGAAGTACTAGAGGATCATAATCAGC
GTGATGGTGATGCTTATCGTCATCGTCGGTACCGCATGCCTCGAGACTGCAGGCTCTAGA
TGCAACCGGTGGAATTCATTTTGAAAAAATTTAC
CAGTCTCGAGCTTCTTTCCTCCTCTTTGAATTTCTC
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amino acids) and G∆TM (512 amino acids) followed by
a His8 (tag)-3’.
2.4. Generation of the recombinant baculovirus
expressing the G∆TM protein
The Bac-to-Bac (baculovirus) expression system
(Invitrogen) was used for the expression of the BipG∆TM.
The recombinant plasmid, pFBip_G∆TM, was transformed
into E.coli DH10Bac (Invitrogen), where the BipG∆TM
was transposed into the bacmid. The purified recombinant
bacmid was transfected into Sf9 cells (Invitrogen) to
generate a recombinant baculovirus (AcMNPV) carrying
the BipG∆TM, AcMNPV_BipG∆TM.
2.5. Expression and purification of truncated G protein
AcMNPV_BipG∆TM was inoculated onto High5 cells for
protein expression at multiplicity of infection (MOI) of 3
and 5. The secreted G∆TM in cell supernatant was collected
at 48 and 72 h postinfection (hpi). The level of protein
expression at each condition was compared by western blot
analysis. The supernatant was clarified by centrifugation at
10,000 rpm at 4 °C for 15 min. The clarified supernatant
was precipitated with 50% (w/v) PEG 6000 (Sigma) to the
final concentration of 8% (w/v). The supernatant was then
stirred at 4 °C for 2 h and centrifuged at 10,000 rpm at
4 °C for 30 min. The supernatant was discarded and the
pellet containing G∆TM was re-suspended in 30 mL of the
binding buffer (20 mM sodium phosphate, 500 mM NaCl,
20 mM imidazole, pH 7.4).
The concentrated G∆TM protein was purified by
affinity chromatography using a HisTrap FF column (GE
Healthcare) with the application provided in a protein
purification platform, AktaStart machine (GE Healthcare).
The column was equilibrated with 15 mL of the binding
buffer at a flow rate of 1 mL/min. The re-suspended pellet
was filtrated through a 0.45 µm filter (Sartaurious) and
diluted with the binding buffer before loading onto the
column at a flow rate 0.8 mL/min. The column was washed
with 15 mL of the binding buffer at a similar flow rate. The
bound proteins were then eluted by a step gradient (13%,
50%, and 100%) with an elution buffer (20 mM sodium
phosphate, 500 mM NaCl, 500 mM imidazole, pH 7.4).
The eluted fractions containing the G∆TM protein were
pooled. Salts in the eluents were decreased by exchanging
with 0.01 mM PBS pH 7.4. The purified G∆TM protein
was concentrated using Amicon Ultra (Millipore) with 30
kDa cut-off.
The purified protein was analyzed by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) in
a 12% gel. The presence of G∆TM protein was confirmed
by western blot using anti-his epitope tag antibody
(Thermo Scientific) as described previously (24).
2.6. Rat immunization
The rat immunization protocol was approved by Kasetsart
University – Animal Care Unit Center (ID-ACKU 59-
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VET-043). Eight-week-old Wistar rats purchased from the
National Laboratory Animal Center (NLAC), Thailand,
were primed subcutaneously once with 40 µg of the
purified G∆TM protein mixed with an equal volume
of complete Freund’s adjuvant (CFA). At 4 weeks after
priming, the rats were boosted subcutaneously with 40 µg
of the purified G∆TM protein mixed with an equal volume
of incomplete Freund’s adjuvant (IFA). The rats were bled
before immunization (d0), before boosting (d28), and
after boosting for 28 days (d56). Two rats were immunized
with PBS-CFA or IFA and served as controls. During
blood collection and antigen immunization, the rats were
sedated by isoflurane inhalation.
2.7. Western blot analysis
Purified G∆TM protein was separated by SDS-PAGE in a
12% gel. Western blot analysis was performed by using antiG∆TM rat sera (1:200 in 3% bovine serum albumin; BSA)
and anti-mouse IgG-HRP (Millipore) (1:2000 in 3% BSA)
as primary and secondary antibodies, respectively. After
each step, the membrane was washed with PBST (0.01 mM
PBS pH 7.4 and 0.1% tween 20) three times. The protein
bands were visualized by adding 3,3’-diaminobenzidine
(DAB).
2.8. Immunoperoxidase monolayers assay (IPMA)
IPMA was performed as previously described (25). Briefly,
AcMNPV_BipG∆TM was inoculated onto High5 cells in
a 96-well plate at an MOI of 3. The plate was incubated
at 26 °C in an incubator (Thermo Scientific). The infected
cells were fixed with methanol when 50% cell death was
observed. The cells were washed once with 1X PBST at
room temperature for 5 min before being incubated with
100 µL of 1% H2O2 in PBS at room temperature for 30 min.
After washing, anti-G∆TM rat sera diluted to an optimal
concentration were incubated with the infected High5 cells
at 37 °C for 1 h. Anti-mouse IgG-HRP (Millipore) diluted
at an optimal concentration was incubated with the bound
antibodies at 37 °C for 1 h. The cells were stained with DAB
(Sigma) and observed for the presence of a brown color.
3. Results
3.1. Expression of BEFV G∆TM in insect cells
A secreted BEFV G protein containing deleted
transmembrane domain and cytoplasmic tail was
successfully produced from insect cells with the application
of the baculovirus expression system. The optimal
condition for G∆TM protein expression was obtained
by inoculating High5 cells with 3 MOI of AcMNPV_
BipG∆TM and the infected cell supernatant was collected
at either 48 or 72 hpi as shown in Figure 1a. The results of
SDS-PAGE and western blot analysis using anti-histidine
tag and anti-mouse IgG-HRP as primary and secondary
antibodies, respectively, showed that the G∆TM proteins
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had a molecular weight of approximately 68 kDa. It
reached the maximum expression level at 48 hpi. When
the amount of the recombinant AcMNPV_BipG∆TM was
increased from 3 to 5 MOI, the expression level was not
different as shown in Figure 1b.
To study the expression of G∆TM in insect cells,
AcMNPV_BipG∆TM was inoculated onto High5 cells
at an MOI of 3 in a 96-well plate for 48 h. The presences
of G∆TM protein in mock- and AcMNPV_BipG∆TMinfected cells were examined by IPMA using either antihistidine tag or a convalescent bovine serum as primary
antibodies. The results showed that the G∆TM protein
appeared mostly at cell periphery and on the plasma
membrane. The protein reacted well with both antihistidine tag and a BEFV-convalescent bovine serum as
shown in Figure 2.
3.2. Purification of G∆TM from cell supernatant
The secreted, soluble form of G∆TM proteins was purified
from infected cell supernatant by PEG precipitation
followed by affinity chromatography. Figure 3 demonstrates
fractions of G∆TM proteins eluted from a nickel column
by a step gradient method. The majority of G∆TM protein
was eluted at 100% elution buffer containing 500 mM
imidazole. The eluted fractions containing G∆TM proteins
were pooled and concentrated before being analyzed by
SDS-PAGE using 12% acrylamide gel. Specificity of the
G∆TM protein was confirmed by western blot. The results
showed that the protein reacted specifically to both anti
8X-his epitope tag antibody and a convalescent bovine
serum as shown in Figure 4.

3.3. Immunogenicity of G∆TM protein
To determine whether G∆TM protein could induce
the specific immune response in animals, rats were
subcutaneously injected with 40 µg of purified G∆TM
protein. Rat serum samples were examined for the
presence of BEFV G protein specific antibodies by western
blot analysis and IPMA. The results showed that all serum
samples from the immunized rats reacted specifically to
the purified G∆TM protein. Sera from preimmunized
rats and nonimmunized control rats did not react to the
protein as shown in Figure 5. The immunized rat sera
also bound specifically to the G protein presented in the
positive cells as shown in Figure 6.
4. Discussion
BEF is one of the most important infectious diseases of
livestock in tropical regions. Cattle infected with BEFV
show clinical signs such as sudden onset of fever and
lethargy, which become a serious management problem
especially in large-scale farming. Vaccines have been
developed and vaccination was applied as a successful
strategy for disease prevention and control (5,23,26–29).
BEFV glycoprotein (G) is an important protein to induce
a protective immune response in cattle (28). Among the
types of vaccines used for BEFV protection, the G protein
expressed from recombinant vaccinia virus and partially
purified virion had promising results in experimental and
field studies (6,30). In fact, the G protein contains four
antigenic sites (G1, G2, G3, and G4) with neutralizing
activities (5,9). All four neutralizing epitopes remained

Figure 1. Soluble G∆TM protein collected from the supernatant of AcMNPV_BipG∆TM infected High5
cells. (a) The secreted G∆TM proteins were collected at 48 and 72 h postinfection (hpi). (b) The proteins
were obtained from High5 cells infected with AcMNPV_BipG∆TM at MOIs of 3 or 5 for 48 hpi.
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Figure 2. G∆TM proteins expressed in infected insect cells examined by immunoperoxidase monolayer assay (IPMA). High5 cells were
mock-infected (a, c) or infected with AcMNPV_BipG∆TM (b, d) at multiplicity of infection (MOI) of 3. The cells were allowed to react
with anti-histidine tag (a and b) or a BEFV convalescent bovine serum (c and d) as primary antibodies.

Figure 3. Immuno-blot photographs demonstrating fractions of secreted G∆TM proteins during purification step. Lanes 1 and 2 are
total protein; lane 3 is flow-through; lanes 4 and 5 are wash fractions containing 20 mM imidazole; lanes 5 and 6 are wash fractions with
65 mM imidazole; lanes 7 and 8 are wash fractions with 250 mM imidazole; lanes 9–18 are elution fractions with 500 mM imidazole.
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Figure 4. Immuno-blot photographs of purified G∆TM protein. The protein band of
approximately 68 kDa reacted specifically to anti-histidine tag antibody (a) or a BEFV
convalescent bovine serum (b).

Figure 5. Immuno-blot photographs showing specific reactivity between G∆TM proteins and immunized rat
sera. The purified G∆TM proteins were incubated with pre- or mock-immunized sera from two control rats (a
and b) or pre- and postimmunized sera from each of four rats (c–f).

on the structure of the soluble form of G protein lacking
C-terminal transmembrane and cytoplasmic tail (amino
acids 522–623) (7).
In our study, we generated baculovirus-expressing
BEFV truncated G protein (G∆TM) as previously

described (7) with a modification on the commercial
Bac-to-Bac expression vector by adding the Drosophila
secretion peptide, namely BiP. The AcMNPV_BipG∆TMinfected cells secreted recombinant G∆TM protein into
supernatant and the protein was purified as a native form.
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Figure 6. G∆TM proteins expressed in AcMNPV_BipG∆TM infected insect cells examined by IPMA assay.
AcMNPV_BipG∆TM was inoculated onto overnight seeded High5 cells in a 96-well plate at an MOI of 3
for 48 h. The infected cells were then fixed and incubated with mock-immunized sera from two control rats
(a and b) or postimmunized sera form four rats (c–f). Horse-radish peroxidase-labeled anti-mouse IgG was
used as a secondary antibody. The brown color was developed by the reactivity between peroxidase and
3,3’-diaminobenzidine (DAB).

The expressed G∆TM protein has approximately 68 kDa
and reacted specifically to either anti-histidine tag or
a BEFV convalescent bovine serum. As demonstrated
by IPMA, the G∆TM localized in cytoplasm and on cell
membrane of the recombinant AcMNPV_BipG∆TMinfected insect cells. Our results also showed that the
recombinant G∆TM was immunogenic as it could induce
the specific antibody production in rats and the protein
could react specifically with a BEFV convalescent serum.

158

In addition, it was shown previously that this form of the G
protein could react specifically with a panel of monoclonal
antibodies raised against BEFV (7). This indicates the
potential use of the soluble, secreted G∆TM protein to
develop a protein-based diagnostic assay for detecting
BEFV infecting cattle.
Ephemeral fever has been found in cattle in Southeast
Asia (4) and may be closely related to East Asian viruses.
Taiwanese BEFV isolates were grouped into the same
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cluster as Japanese and Chinese isolates and were
genetically distant from Australian and Israel isolates
(11,31). Antigenic variations among these strains or even
between field and vaccine strains occurred as amino acid
substitutions were found on the epitopes of G proteins
(11,32). Our G∆TM protein derived from the Asian
cluster of BEFV containing all four antigenic sites on G
protein would be a good candidate antigen for diagnostic
assay development.
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